In April, the BSE Sensex rose nearly 4%, driven by FII inflows, optimistic monsoon forecasts, and progress in India-US trade talks. The RBI's rate cut and a temporary US tariff pau...
The 2024-25 financial year saw a 33% increase in residential home deliveries across India's top nine cities, with Pune leading the growth. Despite a slight decline in Delhi-NCR, th...
Linde plc reported steady Q1 2025 sales of $8.1 billion, with a 5% rise in earnings per share to $3.51. Regional performance was mixed, with growth in the Americas offset by declin...
CVS Health Corporation reported a 7% revenue increase to $94.6 billion in Q1 2025, with net income rising to $1.78 billion. Despite missing expectations, the company revised its 20...
General Motors lowers its 2025 earnings forecast due to $5 billion in exposure from US tariffs, with adjusted profits expected between $10 billion and $12.5 billion. CEO Mary Barra...
Eli Lilly's Q1 revenue jumps 45% to $12.7 billion, fueled by Mounjaro and Zepbound. Net income up 23% to $2.76 billion, with EPS at $3.06. Plans for $50 billion US manufacturing ex...
Biogen Inc. reported a 6% increase in Q1 2025 revenue to $2.4 billion, despite a drop in GAAP diluted EPS to $1.64. CEO Christopher Viehbacher highlights the strategic growth and d...
McDonald's reports a 3% revenue decline in Q1 2025, with net income and earnings per share also dropping. CEO Kempczinski remains confident in the brand's resilience and appeal to ...
